Skip to main content

Karen Segura Dávila

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Karen Segura Dávila

Institutions of which they are part

Administration and Management
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Related news

An international study led by researchers from Vall d’Hebron shows that simple tests that patients can perform themselves help detect changes in disability that may occur even in the absence of disease relapses.

A Vall d’Hebron study, carried out at Cemcat, shows that the risk of inflammatory activity increases after discontinuing treatment, but is considerably reduced in people over 60 years of age.

The project will analyse the functional activation of the NLRP3 inflammasome to advance the early identification of patients at risk of insufficient response to S1P receptor-modulating therapies.

Related professionals

José Raul Herance Camacho

José Raul Herance Camacho

Head of group
Molecular Imaging and Therapy
Read more
Cristina Cea Arestín

Cristina Cea Arestín

Predoctoral researcher
Kidney Physiopathology
Read more
David Berlana Martín

David Berlana Martín

Research technician
Basic, Translational and Clinical Pharmacy Research
Read more
Eulàlia Pérez Esquirol

Eulàlia Pérez Esquirol

Senior researcher
Clinical Pharmacology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.